Prema Abraham MD
Retinal Disease
Medical Director The Retina Center Black Hills Regional Eye Institute
Join to View Full Profile
2800 3rd StRapid City, SD 57701
Phone+1 605-341-2000
Fax+1 605-719-3211
Dr. Abraham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 1993 - 1995
University of Utah HealthResidency, Ophthalmology, 1990 - 1993
University of Arkansas For Medical Sciences College of MedicineClass of 1989
Certifications & Licensure
SD State Medical License Active through 2027
WY State Medical License 2021 - 2026
PA State Medical License 1993 - 1996
UT State Medical License 1990 - 1996
AR State Medical License 1989 - 1991
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Medflow E HR, Medflow Holdings, LLC, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification Medflow EHR, Medflow Holdings, LLC, 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2012-2013
Clinical Trials
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
- Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 69 citationsEffect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.Charles C Wykoff, David M Brown, Kimberly Reed, Alyson J Berliner, Adam T Gerstenblith
JAMA Ophthalmology. 2023-09-01 - 14 citationsProphylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.Clement K Chan, Maziar Lalezary, Prema Abraham, Michael Elman, Wesley Thomas Beaulieu
Ophthalmology. Retina. 2022-06-01 - 1 citationsPost-hoc analysis of single nucleotide polymorphism profile for eyes with vascularized pigment epithelial detachment due to ARMD.Daniel Lee, Clement K. Chan, Prema Abraham, David Sarraf
European Journal of Ophthalmology. 2021-05-01
Press Mentions
Christopher A. Durham, MD, Vascular SurgeonJuly 20th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
